Vertex Pharmaceuticals (VRTX) Change in Intangibles (2023 - 2024)

Vertex Pharmaceuticals' (VRTX) quarterly Change in Intangibles came in at $375.4 million in Q4 2024, up 547.24% year-on-year from $58.0 million in Q1 2024, and up 4975.32% quarter-over-quarter from -$7.7 million in Q2 2024.

Vertex Pharmaceuticals (VRTX) Change in Intangibles (2023 - 2024) Analysis & Trends

Vertex Pharmaceuticals' Change in Intangibles history runs 2 years deep, the most recent figure standing at $375.4 million for Q4 2024.

  • On a quarterly basis, Change in Intangibles rose 547.24% year-over-year to $375.4 million in Q4 2024; TTM through Sep 2025 was $375.4 million, a 389.44% increase from a year earlier, with the FY2024 full-year figure at $187.7 million, up 223.62% from the prior year.
  • Change in Intangibles advanced to $375.4 million in Q4 2024 per VRTX's latest filing, from -$7.7 million in the prior quarter.
  • Across five years, Change in Intangibles topped out at $375.4 million in Q4 2024 and bottomed at -$180.0 million in Q1 2024.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Intangibles (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -66,508.31
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 375.40 Mn
Dec 31, 2024 375.40 Mn
Jun 30, 2024 -7.70 Mn
Jun 30, 2024 -7.70 Mn
Mar 31, 2024 -180.00 Mn
Mar 31, 2024 -180.00 Mn
Dec 31, 2023 58.00 Mn
Dec 31, 2023 58.00 Mn